Filing Details
- Accession Number:
- 0001179110-19-011703
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-14 18:10:13
- Reporting Period:
- 2019-11-12
- Accepted Time:
- 2019-11-14 18:10:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-12 | 6,172 | $0.00 | 15,455 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-11-13 | 2,778 | $16.25 | 12,677 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2019-11-12 | 6,172 | $0.00 | 6,172 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
55,547 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 408,197 | Indirect | Craig Wheeler Revocable Trust |
Common Stock | 36,725 | Indirect | Craig A Wheeler 2016 Annuity Trust |
Common Stock | 60,000 | Indirect | Craig A Wheeler 2018 Annuity Trust |
Footnotes
- Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018.
- Restricted Stock Units convert into common stock on a one-for-one basis.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person November 16,2018.
- This transaction was executed in multiple trades at prices ranging from $16.08 to $16.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.